← 產業報告目錄
Nanopore Sequencing Market Size, Share & Trends Analysis Report, By Product (Instruments, Consumables), By Type of Nanopore (Solid State, Biological, Hybrid), By Type of Nucleotide Sequenced (DNA, RNA), By Application, By End-user, By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-14頁數 180報告編號 INSIGHTACE-ffcaa50805
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 343.0 Mn, the global Nanopore Sequencing Market is expected to advance to USD 1,949.5 Mn by 2034, demonstrating a CAGR of 19.4% during the 2025–2034 forecast window.
At its core, Nanopore Sequencing pertains to a novel, scalable method that enables direct, real-time examination of lengthy dna or rna fragments. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by escalating appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanopore Sequencing Market Snapshot
Chapter 4. Global Nanopore Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Nanopore Sequencing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Radiopharma Industry Trends
Chapter 5. Nanopore Sequencing Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Product:
5.2.1. Instruments
5.2.2. Consumables
Chapter 6. Nanopore Sequencing Market Segmentation 2: By Type of Nanopore, Estimates & Trend Analysis
6.1. Market Share by Type of Nanopore, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Nanopore:
6.2.1. Solid State
6.2.2. Biological
6.2.3. Hybrid
Chapter 7. Nanopore Sequencing Market Segmentation 3: By Type of Nucleotide Sequenced, Estimates & Trend Analysis
7.1. Market Share by Type of Nucleotide Sequenced 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Type of Nucleotide Sequenced:
7.2.1. DNA
7.2.2. RNA
Chapter 8. Nanopore Sequencing Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following Application:
8.2.1. Human Genetics
8.2.2. Clinical Research
8.2.3. Animal Research
8.2.4. Others
Chapter 9. Nanopore Sequencing Market Segmentation 5: By End-user, Estimates & Trend Analysis
9.1. Market Share by End-user, 2023 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 & 2034 for the following End-user:
9.2.1. Biotechnological Companies
9.2.2. Clinical Laboratories
9.2.3. Academic & Research Institutes
9.2.4. Others
Chapter 10. Nanopore Sequencing Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Nanopore Sequencing Market, Regional Snapshot 2023 & 2034
10.2. North America
10.2.1. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.2.3. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.2.4. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.2.5. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.6. North America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.3. Europe
10.3.1. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Denmark
10.3.1.2. Finland
10.3.1.3. Austria
10.3.1.4. France
10.3.1.5. Germany
10.3.1.6. Israel
10.3.1.7. Italy
10.3.1.8. Netherlands
10.3.1.9. Norway
10.3.1.10. Poland
10.3.2. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.3.3. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.3.4. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.3.5. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.6. Europe Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. Australia
10.4.1.2. China
10.4.1.3. India
10.4.1.4. Indonesia
10.4.1.5. Japan
10.4.1.6. Malaysia
10.4.1.7. Philippines
10.4.1.8. Singapore
10.4.1.9. South Korea
10.4.1.10. Taiwan
10.4.1.11. Thailand
10.4.1.12. Rest of APAC
10.4.2. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.4.3. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.4.4. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts By Type of Nucleotide Sequenced 2021-2034
10.4.5. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.6. Asia Pacific Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.5. Latin America
10.5.1. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Argentina
10.5.1.2. Brazil
10.5.1.3. Mexico
10.5.1.4. Rest of LATAM
10.5.2. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.5.3. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.5.4. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.5.5. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.6. Latin America Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. Egypt
10.6.1.2. Israel
10.6.1.3. Nigeria
10.6.1.4. Saudi Arabia
10.6.1.5. Qatar
10.6.1.6. United Arab Emirates
10.6.1.7. Rest of MEA
10.6.2. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.6.3. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanopore, 2021-2034
10.6.4. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nucleotide Sequenced 2021-2034
10.6.5. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.6. Middle East & Africa Nanopore Sequencing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Pacific Biosciences
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Modeance
11.2.1.5. Geographical Presence
11.2.1.6. Recent Developments with Business Strategy
11.2.2. Oxford Nanopore Technologies Limited
11.2.3. QIAGEN
11.2.4. Eurofins Scientific
11.2.5. Agilent Technologies, Inc.
11.2.6. F. Hoffmann-La Roche Ltd.
11.2.7. Bio-Rad Laboratories, Inc.
11.2.8. Danaher Corporation, PerkinElmer Inc.
11.2.9. Thermo Fisher Scientific
11.2.10. Myriad Genetics, Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們